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Effects of glucagon and forskolin on the phosphorylation and changes of activity of carnitine palmitoyl- 
transferase (CPT) have been studied in isolated rat hepatocytes using anti-CPT immunoglobulin. When the 
activity was determined in lysed hepatocytes after glucagon or forskolin treatment, it was found to be stimu- 
lated 30-80x mainly through increased affinity for palmitoyl-CoA. By SDS electrophoresis of the immuno- 
precipitates, CPT subunit (Mr 69000) was noted to be phosphorylated 45-fold with glucagon (1.2 x lo-’ 
M) and forskolin (0.1 mM) over control. These results indicate that hepatic ketogenesis is regulated with 
glucagon by phosphorylation of CPT through CAMP-dependent protein k ase. 
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1. INTRODUCTION 
Glucagon has been shown to stimulate hepatic 
ketogenesis probably through the stimulation of 
the carnitine palmitoyl-transferase (CPT) step 
[l-3]. A lowered malonyl-CoA level following 
glucagon has been advocated to stimulate the CPT 
step since malonyl-CoA is an inhibitor for CPT [4]. 
Although recipkocal changes of ketogenesis and 
fatty acid synthesis (malonyl-CoA level) are the 
basis for this theory, direct proof has not yet been 
provided. The mode of inhibition of CPT with 
malonyl-CoA is competitive with palmitoyl-CoA 
and therefore it is unlikely that the small changes 
of malonyl-CoA level regulate ketogenesis from 
exogenous palmitate (0.3-0.5 mM). 
for malonyl-CoA inhibition of CPT was much 
greater in mitochondria from starved or ketotic 
diabetic rats. 
Here, the possibility of covalent modification of 
CPT through phosphorylation was studied in lysed 
hepatocytes after incubation with glucagon or for- 
skolin for 15-30 min. In addition to the activities 
of CPT, 32P incorporation into CPT was simul- 
taneously determined using anti-CPT immuno- 
globulin which was obtained in rabbit by injecting 
purified rat liver CPT [7]. 
2. METHODS 
2.1. Isolation of hepatocytes 
We have shown the direct activation of CPT in Hepatocytes were isolated as described before 
mitochondria isolated from hepatocytes after with a cell viability over 95% from rats fed on 
treatment with glucagon for 30 min, and proposed laboratory chow [5]. The usual cell suspension 
a direct regulatory mechanism of CPT by glucagon (400-600 x 104/ml) in Krebs-Ringer-bicarbonate 
and insulin [5]. Cook et al. [6] also reported that buffer (pH 7.4) contains 30-40 mg/ml protein con- 
the inhibitor concentration giving 50% inhibition centration. 
Published by Elsevier Science Publishers B. V. (Biomedical Division) 
00145793/85/$3.30 0 1985 Federation of European Biochemical Societies 267 
Volume 188, number 2 FEBS LETTERS September 1985 
2.2. ~~rrn~~a~ treatment and preparation of cell 
lysate 
Hepatocytes corresponding to 80-120 mg pro- 
tein were preincubated with 32P in phosphate-free 
Krebs-Ringer-Hepes buffer (pH 7.4) containing 
2% bovine albumin in 2.6 ml for 30 min at 37°C 
in a conical flask. Then glucagon, insulin or 
forskolin was added and the mixture was further 
incubated for 15 and 30 min for study of 32P incor- 
poration and assay of CPT activity, respectively. 
Cells were washed with ice-cold 0.25 M sucrose 
containing 5 mM Hepes buffer (pH 7.4), 1 mM 
NaF, 0.1 mM EDTA 4 times by centrifugation at 
1000 rpm for 3 min. 0.5 ml of 0.5% Triton X-100 
was added to the cell precipitate, and the mixture 
frozen at -20°C for cell lysis. Then the lysed cell 
suspension was centrifuged at 1 x 1O’xg for 60 
min. CPT activity was determined using an aliquot 
of the supernatant by measuring carnitine- 
dependent CoA release from palmitoyl-CoA using 
a Shimazu UV 300 dual wave-length spec- 
trophotometer [5]. 
2.3. r~~~~opre~ipitati~~ of CPT 
To an aliquot of the supernate (0.2 ml), a suffi- 
cient amount of anti-CPT immunoglobulin (4 mg) 
was mixed and left overnight at 4°C. No activity 
was detectable in the supernate after centrifuga- 
tion. The precipitate was washed 3 times with 0.15 
M NaCl, 50 mM Tris-HCI buffer (pH 7.4), 2% 
Triton X-100, and once with 10 mM NaCI, 0.1% 
(w/v) SDS, 2 mM EDTA, 0.1% (v/v) Triton 
X-100. Finally, the washed precipitate weas mixed 
with 75 ,ul of the previous buffer containing DTT, 
and heated at 100°C for 10 min. The properties of 
the antibody against purified CPT from rat liver 
loo- 
t half maximal stimulation 
80- 
Glucagon or Forskolin (Mole/l) 
Fig. 1. Dose-responsive stimulation of hepatic ketogenesis by glucagon and forskolin in isolated rat hepatocytes. 
Hepatocytes were incubated with 0.3 mM ~-14CJpaimitate bound to 0.3 mM albumin in the presence or absence of 
various concentrations of glucagon or forskolin [5]. The reaction was terminated by 3% PCA and the radioactivity 
determined in the supernate as described [5]. 
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mitochondria have been described [7]. 1 mg IgG 
precipitated CPT corresponding to an activity of 
1.7 nmol/min in the presence of 0.5% Triton. 
2.4. SDS-polyacrylamide gel electrophoresis 
Electrophoresis was carried out by the method 
of Weber and Osborn [8] using 10% polyacryl- 
amide gel. The markers used were phosphorylase 
b, 97.4 kDa; bovine serum albumin, 67 kDa; 
GDH, 55.4 kDa and LDH, 36.5 kDa. The peptide 
was stained by Coomassie blue R-250. The density 
was determined by the transmission of light at 600 
nm against 750 nm as a reference using a Shimazu 
Densitometer. 
2.5. Autoradiography of CPT immunoprecipitate 
obtained from cell lysate prelabelled with 32P 
After staining for protein, the gel was covered 
with film (AR film Kodak X-Omat), and kept at 
-20°C for 2 weeks. After development, the 32P- 
labelled band was quantified by reflection of light 
at 600 nm using the Shimazu Densitometer. 
3. RESULTS 
3.1. Dose-responsive stimulation of ketogenesis 
by glucagon and forskolin in isolated rat 
hepatocytes 
Ketogenesis from [U-r4C]palmitate was stimu- 
lated by glucagon and forskolin in a dose-respon- 
0 042 rnM Ix (mMf Pal CoA 
Fig.2. Lineweaver-Burk plots of CPT activity in relation 
to palmitoyl-CoA concentrations. Freshly isolated 
hepatocytes were incubated with or without 6.0 x lo-* M 
glucagon for 30 min. Cells were centrifuged down, lysed 
with 0.5% Triton, then centrifuged at 1 x lo5 x g for 60 
min. CPT activity was determined in the presence of 1 
mM NaF using an aliquot of the supernate [5]. 
Fig.3. Peptide staining after SDS-polyacrylamide gel 
electrophoresis of CPT immunoprecipitate. Hepatocytes 
were preincubated with 32P for 30 min. 15 min after the 
hormonal addition, the cells were lysed by 0.5% Triton 
and anti-CPT IgG was added to the lysed cell supernate. 
The precipitate was washed as described in section 2 and 
the peptide stained with Coomassie blue. (A) Control, 
(B) 6.9 x lo-* M insulin, (C) 5.8 x 10e9 M glucagon, (D) 
1.2x lo-’ M glucagon, (E) 0.1 mM forskolin. 
sive manner as shown in fig. 1. Maximum stimula- 
tion (90% over control) was observed at lo-’ M 
glucagon. A 70% stimulation was observed at 0.1 
mM forskolin. 
3.2. Activation of carnitine palmitoyltransferase 
by glucagon and forskolin 
Mean CPT activity at 20 and 80 PM palmitoyl- 
CoA for the control was 3.4 f 0.56 and 12.6 + 0.89 
nmol/mg protein per min (mean+ SE, n = 12), 
respectively. Glucagon (6.0x 10e8 M) or forskolin 
(0.1 mM) treatment for 30 min enhanced CPT ac- 
tivity by 70-80% at 20/1M palmitoyl-CoA and by 
30-50‘70 at 80 PM palmitoyl-CoA over normal. 
Lineweaver-Burk plots revealed that Km for 
palmitoyl-CoA in the control lysed hepatocytes 
was 42 pmol/ml, which decreased to 18 pmol/ml in 
the cell lysate after glucagon treatment (fig.2). A 
similar increase of the affinity for palmitoyl-CoA 
was observed for forskolin. 
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3.3. SDS-polyacrylamide gel electrophoresis of 
the immuno-precipitate after incubation of 
the cell supernatant with anti-CPT igG 
There are at least 4 bands (iw, 83~, 77000, 
69000, 67000) other than those derived from the 
heavy or light chains of IgG (fig.3). A protein band 
corresponding to A4,69000 was identical with the 
CPT subunit (M, 69200), which has been demon- 
strated by Miyazawa et al. [7]. The other 3 protein 
bands were not identified, but seemed to be poly- 
peptides derived from coprecipitate with CPT an- 
tibody. 
3.4. Effect of glucagon, insulin or forskolin on 
32P ~abellin~ of the CPT subunit 
Fig.4 shows an autoradiogram taken after SDS 
gel electrophoresis of CPT precipitated with anti- 
CPT IgG. The CPT subunit (Mr 69 000) was darkly 
stained in samples obtained from glucagon (1.2 x 
Fig.4. Autoradiography of CPT immunoprecipitate 
obtained from cell lysate after various hormonal 
treatments. An autoradiogram was obtained as de- 
scribed in section 2. Sample application from A to E was 
the same as in fig.3. 
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Table 1 
Specific 32P incorporation into immunoprecipitable 
CPT separated by polyacrylamide gel electrophoresis 
Treatment 32P incorporation to CPT 
band/protein concentra- 
tion of CPT band 
_______.. 
% Fold over 
control 
Control 6.8 1 
Insulin (6.9 x lo-* M) 8.2 1.2 
Glucagon (5.8 x lo-’ M) 10.6 1.6 
Glucagon (1.2 x lo-’ M) 32.1 4.7 
Forskolin (1 x 10d4 M) 25.3 3.7 
10’ M) or forskolin (0.1 mM) treated hepatocytes, 
and only vague lines were visible in samples from 
the control, insulin or Iow glucagon (5.8 x low9 
M)/l-treated hepatocytes. The other distinct stain- 
ing which was as dark as the CPT subunit, was 
observed in the larger polypeptide band (ME 
83000). However, the nature of this peptide has 
not yet been identified. The other 2 polypeptide 
bands (&& 77 000 and 67 000) seen in fig.3 were not 
phosphorylated under the incubation conditions. 
The ratio of 32P incorporation into the CPT 
subunit to the amount of peptide determined by 
densitometry is shown in table 1. While insulin 
treatment had no effect on the 32P incorporation 
into CPT, the low dose of glucagon stimulated 
1.6”fold, and 1.2x 10e7 M glucagon and forskolin 
stimulated 32P incorporation into CPT subunit by 
4.7- and 3.7-times, respectively, over the control 
(table 1). 
4. DISCUSSION 
Carnitine palmitoyltransferase activity was 
determined in lysed hepatocytes with 0.5% Triton 
rather than in isolated mitochondria after incuba- 
tion with hormones for 30 min. This method omit- 
ted the mitochondrial isolation step and enabled 
estimation of total CPT activity without any loss in 
recovery. In our previous report, CPT 1 was 
shown to be increased in mitochondria isolated 
from hepatocytes treated with glucagon for 30 min 
[5]. Here, we have not attempted to quantify CPT 
1 and 2, but aimed to determine the changes in 
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total CPT activity following the hormonal treat- 
ment. During the purification step of CPT in rat 
liver, Miyazawa et al. [7] were unable to find 
heterogeneous CPT in solubilized rat liver mito- 
chondria, and only a single precipitation line was 
observed in the immuno-diffusion plates between 
liver extract and anti-CPT IgG. Thus, CPT 1 and 
2 may be the same protein, although it is localized 
both inside or outside the barrier for acyl-CoA 
transport as shown by Hoppel and Tomex [9]. The 
identical properties of both CPT 1 and 2 have been 
reported by Bergstrom and Reitz [lo]. The CTP 
activity was found to increase in lysed hepatocytes 
after glucagon or forskolin treatment. The in- 
creased CPT activity was mainly attributed to the 
increase in affinity for palmitoyl-CoA rather than 
Max, when analyzed by Lineweaver-Burk plots. 
This is consistent with the observation that in 
isolated hepatocytes, enhanced palmitate oxida- 
tion was more significant at lower concentrations 
(0.1-0.5 mM) rather than at higher concentrations 
(0.5-1.0 mM) of palmitate. 
When 32P incorporation into the CPT subunit 
was studied in lysed hepatocytes, the obvious 32P 
incorporation was demonstrated by radioauto- 
graphy in the CPT subunit obtained from glucagon 
or forskolin treated hepatocytes. The weaker 
stimulation of phosphorylation with lower concen- 
trations of glucagon is consistent with the observa- 
tion that stimulation of palmitate oxidation with 
glucagon is not maximal at lower glucagon levels 
because of the considerable degradation occurring 
during incubation. The nature of the other poly- 
peptide (Mr 83000) which was also highly phos- 
phorylated with glucagon or forskolin was not 
identified. This polypeptide is larger than the 
precursor of CPT(71 kDa) [ 111. Since the antibody 
was found to be unreactive with carnitine octanoyl- 
transferase or acetylcarnitine transferase, these 
bands are most likely to be coprecipitates of the 
proteins which tightly bound to CPT and copre- 
cipitated with anti-CPT. Carnitine translocase 
seemed to be tightly bound to CPT and this might 
be one of the possibilities. 
This study has presented suggestive vidence for 
the phosphorylation of CPT. An activation of 
CPT was also observed 15 min after the hormonal 
treatment, indicating that the activation is most 
likely due to the consequence of enzyme phos- 
phorylation. A dose-response stimulation of keto- 
genesis from exogenous palmitate (0.3-0.5 mM) 
with glucagon or forskolin is better explained by 
covalent modification of CPT itself rather than the 
small changes in endogenous malonyl-CoA level as 
proposed by McGarry et al. [4]. Palmitate oxida- 
tion has been shown by our laboratory [12] to be 
stimulated by epinephrine through ar-adrenergic 
receptor. Since esterification of palmitate was not 
affected by epinephrine, the stimulation of palmi- 
tate oxidation may be mediated through Ca- 
calmodulin dependent protein kinase. The phos- 
phorylation of CPT with epinephrine has not been 
investigated here. 
In this study, CPT was determined in hepato- 
cytes treated with glucagon or forskolin for 30 min 
in contrast to 15 min in the case of 32P-labelling ex- 
periments. However, activation of CPT was also 
noted at 15 min after glucagon or forskolin addi- 
tion. Activated CPT seemed to be less sensitive to 
malonyl-CoA inhibition, since 20 pmol/l malonyl- 
CoA inhibited CPT by 50-60 or 20-30070 in lysed 
cells treated with saline or glucagon, respectively. 
In this study, CPT activity was determined in a 
lysed cell supernate. However, the K, for palmi- 
toyl-CoA was similar to that in isolated intact 
mitochondria from control or glucagon-treated 
hepatocytes (Km, 25 and 13 PM for control and 
glucagon-treated mitochondria). Also, inhibition 
of malonyl-CoA (Ki 25 PM) in intact mitochondria 
from control hepatocytes was similar to that in 
lysed hepatocytes. The Ki value was lo-times 
higher than that reported by McGarry et al. They 
reported that in a lysed mitochondria, malonyl- 
CoA became less inhibitory, although the mechan- 
sim was not shown. Hepatocytes which were 
freshly isolated from meal-fed rats were reported 
to contain 2.5 + 0.2 nmol malonyl-CoA per g cells 
[13]. It is questionable that CPT activity is only 
regulated by changes in this low level of malonyl- 
CoA. Under certain conditions, malonyl-CoA may 
play a role in the regulation of hepatic fatty acid 
oxidation, but covalent modification of CPT 
through phosphorylation may play a more impor- 
tant role in the mechanism of hormonal control of 
hepatic fatty acid oxidation. 
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